MS patients report excellent compliance with oral prednisone for acute relapses

Canadian Journal of Neurological Sciences

Volumn 39, Issue 3, 2012, Pages 352-354

  Morrow, Sarah A ^a   McEwan, Lynn ^a   Alikhani, Katayoun ^b   Hyson, Christopher ^a   Kremenchutzky, Marcelo ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADULT; AGITATION; APPETITE; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; EUPHORIA; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MULTIPLE SCLEROSIS; NAUSEA; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SIDE EFFECT;

EID: 84860453966     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100013500     Document Type: Article

References (20)

1. Beck CA, Metz LM, Svenson LW, Patten SB. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler. 2005;11: 516-19. (Pubitemid 41387694)
2. Murray TJ. Diagnosis and treatment of multiple sclerosis. BMJ. 2006;332:525-7. (Pubitemid 44364370)
3. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000;343:1430-8.
4. Beck RW, Cleary PA, Backlund JC. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Ophthal. 1994;101:1771-8.
5. Sellebjerg F, Barnes D, Filippini G, et al. EFNS guideline on treatment of multiple sclerosis relapses: Report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol. 2005;12:939-46. (Pubitemid 41820048)
6. Goodin DS, Frohman EM, Garmany GP Jr, et al. Disease modifying therapies in multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and theMS Council for Clinical Practice Guidelines. Neurology. 2002;58:169-78. (Pubitemid 34086933)
7. Metz LM, Harris CJ, Moore A. MS patients' choice of oral rather than IV steroid therapy results in savings to health care system. International Journal of MS Care (serial on the internet) 2000; March (cited 2010 Sept). Available at www.mscare.org
8. Martinelli V, Rocca MA, Annovazzi P, et al. A short-term randomized MRI study of high-dose oral vs. intravenous methylprednisolone in MS. Neurology. 2009;73:1842-8.
9. Morrow SA, Stoian CA, Dmitrovic J, Chan SC, Metz LM. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. Neurology. 2004;63:1079-80. (Pubitemid 39287919)
10. Burton JM, O'Connor PW, Hohol M, Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev 2009:CD006921.
11. Metz LM, Sabuda D, Hilsden RJ, Enns R, Meddings JB. Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis. Neurology. 1999;53:2093-6.
12. Beck RW, Cleary PA, Anderson MM Jr., et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992;326:581-8.
13. Trobe JD, Sieving PC, Guire KE, Fendrick AM. The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists. Ophthalmology. 1999;106:2047-53. (Pubitemid 30194223)
14. Tse FL, Welling PG. Relative bioavailability of prednisone and prednisolone in man. J Pharm Pharmacol. 1979;31:492-3. (Pubitemid 9201656)
15. Morrow SA, Metz LM, Kremenchutzky M. High dose oral steroids commonly used to treat relapses in Canadian MS clinics. Can J Neurol Sci. 2009;36:213-15.
16. Goff DC, Hill M, Freudenreich O. Treatment adherence in schizophrenia and schizoaffective disorder. J Clin Psychiatry. 2011;72:e13.
17. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13: 7-23.
18. World Health Organization (WHO). Adherence to long-term therapies. Evidence for action. 2003. Available at http://whqlibdoc.who.int/publications/ 2003/9241545992.pdf
19. Hohl CM, Abu-Laban RB, Brubacher JR, et al. Adherence to emergency department discharge prescriptions. CJEM 2009;11: 131-8.
20. Llor C, Hernandez S, Sierra N, Moragas A, Hernandez M, Bayona C. Association between use of rapid antigen detection tests and adherence to antibiotics in suspected streptococcal pharyngitis. Scand J Prim Health Care. 2010;28:12-17.